PCLRX Performance — PGIM Income Builder Fund, Class R
Data updated: 2026-09-29
PCLRX returned +7.96% year to date and +14.20% over one year to Jul 2026. Annualised returns are +13.00% over 3 years and +6.61% over 5 years. The fund trailed its US Blend category average: $100 invested three years ago grew to $144, against $147 for the category, and to $114 over one year, against $120. Volatility over the past three years was 8.02% a year. In the 12 months to Jul 2026 the fund lost a net $4.3M, and assets reached $254.73M.
PCLRX Growth of $100
What $100 invested in PGIM Income Builder Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Blend category average over the same months.
| Period | PCLRX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $114 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $144 | $147 |
| 5 years (Aug 2021 – Jul 2026) | $138 | $143 |
| Since data start (Aug 2019 – Jul 2026) | $160 | $176 |
PCLRX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.96% |
| 1 year | +14.20% |
| 3 years (annualised) | +13.00% |
| 5 years (annualised) | +6.61% |
PCLRX Annual Returns
Calendar-year total returns of PGIM Income Builder Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +7.96% |
| 2025 | +13.98% |
| 2024 | +12.61% |
| 2023 | +10.42% |
| 2022 | −11.20% |
| 2021 | +10.07% |
| 2020 | +2.43% |
| 2019 (Aug–Dec) | +4.37% |
PCLRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +3.0% | +3.5% | −3.7% | +4.6% | +0.5% | +1.1% | −1.0% | — | — | — | — | — |
| 2025 | +2.3% | +1.6% | −1.0% | −0.5% | +2.2% | +3.0% | 0.0% | +2.0% | +2.1% | −0.1% | +1.4% | +0.4% |
| 2024 | −0.3% | +1.8% | +2.9% | −2.6% | +2.8% | +1.3% | +2.6% | +3.0% | +2.1% | −1.2% | +3.0% | −3.2% |
| 2023 | +4.3% | −2.9% | +0.6% | +1.0% | −2.1% | +2.9% | +2.3% | −1.5% | −2.3% | −2.1% | +6.1% | +4.2% |
| 2022 | −1.7% | −2.1% | +0.3% | −4.6% | +1.2% | −6.8% | +4.7% | −2.0% | −7.1% | +3.7% | +5.6% | −2.0% |
| 2021 | −0.1% | +1.8% | +1.4% | +2.9% | +1.8% | +0.6% | 0.0% | +0.9% | −1.7% | +2.1% | −2.7% | +2.9% |
| 2020 | −0.3% | −5.2% | −17.4% | +7.2% | +4.6% | +2.1% | +4.0% | +2.7% | −1.8% | −0.8% | +7.1% | +2.8% |
| 2019 | — | — | — | — | — | — | — | −0.5% | +1.3% | +0.2% | +0.3% | +3.1% |
PCLRX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 8.02%
- 3-year Sharpe ratio: 1.06 (vs 4.5% risk-free rate)
- Best month: +6.08% (Nov 2023)
- Worst month: −3.72% (Mar 2026)
PCLRX Fund Flows
Monthly money in and out of PGIM Income Builder Fund, from SEC Form N-PORT.
- 12-month net flow: −$4.3M
- 12-month gross sales (incl. reinvestments): $50.7M
- Sales ÷ redemptions: 0.92×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $4.1M | $3.5M | $674K |
| Jun 2026 | $3.4M | $5.7M | −$2.3M |
| May 2026 | $3.6M | $5.3M | −$1.7M |
| Apr 2026 | $2.8M | $4.7M | −$1.9M |
| Mar 2026 | $4.5M | $4.3M | $234K |
| Feb 2026 | $5.6M | $5.1M | $495K |
| Jan 2026 | $4.2M | $4.1M | $50K |
| Dec 2025 | $4.7M | $4.4M | $219K |
| Nov 2025 | $4.4M | $3.9M | $451K |
| Oct 2025 | $4.6M | $5.2M | −$578K |
| Sep 2025 | $4.5M | $4.6M | −$130K |
| Aug 2025 | $4.4M | $4.3M | $95K |
PCLRX Assets Under Management
Net assets of PGIM Income Builder Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $254.73M |
| 2026-04-30 | $258.06M |
| 2026-01-30 | $250.86M |
| 2025-10-31 | $243.46M |
| 2025-07-31 | $236.72M |
| 2025-04-30 | $230.95M |
| 2025-01-31 | $234.88M |
| 2024-10-31 | $237.92M |
| 2024-07-31 | $236.49M |
| 2024-04-30 | $229.03M |
| 2024-01-31 | $236.98M |
| 2023-10-31 | $223.17M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.